Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice
- 1 April 2008
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 127 (1), 41-49
- https://doi.org/10.1016/j.jconrel.2007.12.014
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing miceJournal of Controlled Release, 2006
- Properties of HPMA copolymer–doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modificationJournal of Controlled Release, 2006
- Polymeric conjugates of mono- and bi-cyclic αVβ3 binding peptides for tumor targetingJournal of Controlled Release, 2006
- Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxelJournal of Controlled Release, 2006
- Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumorJournal of Controlled Release, 2005
- Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in miceJournal of Biomedical Optics, 2005
- SEVERE NEUROTOXICITY, OTOTOXICITY AND NEPHROTOXICITY FOLLOWING HIGH-DOSE CISPLATIN AND AMIFOSTINEPediatric Hematology and Oncology, 2005
- Recent advances on chitosan-based micro- and nanoparticles in drug deliveryJournal of Controlled Release, 2004
- Physicochemical Characteristics of Self-Assembled Nanoparticles Based on Glycol Chitosan Bearing 5β-Cholanic AcidLangmuir, 2003
- Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effectJournal of Controlled Release, 2003